Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Meitav Global Technology Stocks (0P0000A77O)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
564.950 +1.170    +0.21%
24/04 - Closed. Currency in ILS ( Disclaimer )
  • Morningstar Rating:
  • Total Assets: 187.87M
Type:  Fund
Market:  Israel
Issuer:  Meitav DS Mutual Funds Ltd
ISIN:  IL0051010192 
S/N:  5101019
Asset Class:  Equity
Meitav Biotechnology 564.950 +1.170 +0.21%

0P0000A77O Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Meitav Biotechnology (0P0000A77O) fund. Our Meitav Biotechnology portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 3.630 3.650 0.020
Stocks 95.120 95.120 0.000
Bonds 1.250 1.250 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 22.561 26.224
Price to Book 6.670 4.978
Price to Sales 5.763 4.292
Price to Cash Flow 17.081 16.511
Dividend Yield 1.043 0.863
5 Years Earnings Growth 12.789 14.888

Sector Allocation

Name  Net % Category Average
Technology 42.040 64.542
Financial Services 18.310 6.532
Communication Services 17.080 13.590
Healthcare 6.240 4.921
Industrials 5.730 6.891
Consumer Cyclical 4.540 8.725
Energy 4.030 2.253
Consumer Defensive 2.030 1.873

Region Allocation

  • North America
  • Europe Developed
  • Asia
  • Africa & Middle East
  • Developed Markets

Top Holdings

Number of long holdings: 31

Number of short holdings: 1

Name ISIN Weight % Last Change %
  Alphabet C US02079K1079 6.98 173.69 +9.97%
  Apple US0378331005 6.59 169.30 -0.35%
  Technology Select Sector SPDR US81369Y8030 6.14 199.76 +1.09%
  Microsoft US5949181045 6.13 406.32 +1.82%
  Constellation Software CA21037X1006 4.82 3,635.00 -0.55%
  Next Vision IL0011765935 4.53 4,811.00 -0.54%
  Novo Nordisk ADR US6701002056 4.42 126.86 +0.85%
  Visa A US92826C8394 4.10 274.58 -0.21%
  VeriSign US92343E1029 4.05 175.48 -3.94%
  Mastercard US57636Q1040 3.90 462.23 +0.03%

Top Equity Funds by Meitav Mutual Funds Ltd

  Name Rating Total Assets YTD% 3Y% 10Y%
  Tachlit TTF S&P 500 1.21B 11.44 14.82 13.05
  Meitav 20 80 1.18B 2.60 2.50 -
  Tachlit TTF S&P 500 Hedged 1.06B 9.70 8.75 -
  Tachlit TTF TLV 125 790.32M 8.28 7.10 4.72
  Meitav Bond Portfolio + 30 598.68M 3.51 4.08 3.69
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000A77O Comments

Write your thoughts about Meitav Global Technology Stocks
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email